Monopar Therapeutics Inc.
Skokie Blvd., Suite 350
Securities and Exchange Commission
of Corporation Finance
Registration Statement on Form S-1
File No. 333-233303
prior correspondence, dated November 5, 2019, Monopar Therapeutics
Inc. (the “Company”) requested that the
above-referenced Registration Statement be declared effective at 4
p.m., Eastern time, on November 7, 2019 (the “Acceleration
Request”). The Acceleration Request is hereby withdrawn by
contact John Harrington of Baker & Hostetler LLP at (216)
861-6697 with any questions regarding the foregoing.
/s/ Chandler D.